Evidence map›Paper›PMID 15827170›Full record

ArticleJournal of virology2005

ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.

Cagan Gurer, Anders Höglund, Stefan Höglund, Jeremy Luban

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Heat shock proteins and viral infection.Frontiers in immunology · 2022
    Review
  4. Review
  5. ATeam technology for detecting early signs of viral cytopathic effect.The Journal of veterinary medical science · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Cagan GurerDepartment of Microbiology and Medicine, Columbia University, 701 W. 168th Street, New York, NY 10032, USA.
Anders Höglund
Stefan Höglund
Jeremy Luban
Uppsala University · SEColumbia University · US

Funding

MOLECULAR DESCRIPTION OF HIV1 GAG ASSEMBLYR01AI041857 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LUBAN, JEREMY · 1997 to 2005
$1.3M
NIAID NIH HHS R01 AI041857NIAID NIH HHS R01AI41857
6 · The paper itself

Abstract

Heat shock protein 70 (Hsp70) is incorporated within the membrane of primate lentiviral virions. Here we demonstrate that Hsp70 is also incorporated into oncoretroviral virions and that it remains associated with membrane-stripped human immunodeficiency virus type 1 (HIV-1) virion cores. To determine if Hsp70 promotes virion infectivity, we attempted to generate Hsp70-deficient virions with gag deletion mutations, Hsp70 transdominant mutants, or RNA interference, but these efforts were confounded, largely because they disrupt virion assembly. Given that polypeptide substrates are bound and released by Hsp70 in an ATP-hydrolytic reaction cycle, we supposed that incubation of HIV-1 virions with ATP would perturb Hsp70 interaction with substrates in the virion and thereby decrease infectivity. Treatment with ATP or ADP had no observable effect, but ATPgammaS and GTPgammaS, nucleotide triphosphate analogues resistant to Hsp70 hydrolysis, dramatically reduced the infectivity of HIV-1 and murine leukemia virus virions. ATPgammaS-treated virions were competent for fusion with susceptible target cells, but viral cDNA synthesis was inhibited to an extent that correlated with the magnitude of decrease in infectivity. Intravirion reverse transcription by HIV-1, simian immunodeficiency virus, or murine leukemia virus was also inhibited by ATPgammaS. The effects of ATPgammaS on HIV-1 reverse transcription appeared to be indirect, resulting from disruption of virion core morphology that was evident by transmission electron microscopy. Consistent with effects on capsid conformation, ATPgammaS-treated viruslike particles failed to saturate host antiviral restriction activity. Our observations support a model in which the catalytic activity of virion-associated Hsp70 is required to maintain structural integrity of the virion core.

Indexed as

Adenosine TriphosphateAnimalsCell LineGene DeletionGenes, gagGuanosine 5'-O-(3-Thiotriphosphate)HIV-1HIV InfectionsHIV Reverse TranscriptaseHSP70 Heat-Shock ProteinsHumansLeukemia Virus, MurineRatsRetroviridae InfectionsReverse Transcriptase InhibitorsTumor Virus Infectionsadenosine 5'-O-(3-thiotriphosphate)Adenosine TriphosphateGuanosine 5'-O-(3-Thiotriphosphate)HIV Reverse TranscriptaseHSP70 Heat-Shock ProteinsReverse Transcriptase Inhibitors

Identifiers

PMID15827170
PMCPMC1082765
OpenAlexW2127416395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.